|
Rodent Models of Amyotrophic Lateral Sclerosis
|
journal
|
June 2015 |
|
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
|
journal
|
March 2012 |
|
TDP‐43 mutation in familial amyotrophic lateral sclerosis
|
journal
|
April 2008 |
|
Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice
|
journal
|
November 2014 |
|
Adeno‐associated virus–delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model
|
journal
|
March 2016 |
|
MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS
|
journal
|
May 2012 |
|
Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis
|
journal
|
June 1994 |
|
Dysregulation of microRNA biogenesis machinery and microRNA/RNA ratio in skeletal muscle of amyotrophic lateral sclerosis mice
|
journal
|
December 2017 |
|
Impairment of retrograde axonal transport in wobbler mouse motor neuron disease
|
journal
|
February 1990 |
|
p53 Is Abnormally Elevated and Active in the CNS of Patients with Amyotrophic Lateral Sclerosis
|
journal
|
December 2000 |
|
A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis
|
journal
|
January 1987 |
|
Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis
|
journal
|
January 2000 |
|
Glial nuclear aggregates of superoxide dismutase-1 are regularly present in patients with amyotrophic lateral sclerosis
|
journal
|
February 2011 |
|
Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion
|
journal
|
September 2012 |
|
The wobbler mouse, an ALS animal model
|
journal
|
March 2013 |
|
miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients
|
journal
|
August 2014 |
|
Chronic Exposure to Dietary Sterol Glucosides is Neurotoxic to Motor Neurons and Induces an ALS–PDC Phenotype
|
journal
|
January 2008 |
|
Identification of miRNAs as Potential Biomarkers in Cerebrospinal Fluid from Amyotrophic Lateral Sclerosis Patients
|
journal
|
April 2016 |
|
Increased Expression of MicroRNA-29a in ALS Mice: Functional Analysis of Its Inhibition
|
journal
|
April 2014 |
|
Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage
|
journal
|
June 2017 |
|
Cortical Neurotoxic Astrocytes with Early ALS Pathology and miR-146a Deficit Replicate Gliosis Markers of Symptomatic SOD1G93A Mouse Model
|
journal
|
July 2018 |
|
The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
|
journal
|
October 1997 |
|
Amyotrophic lateral sclerosis
|
journal
|
March 2011 |
|
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
|
journal
|
May 2013 |
|
Amyotrophic lateral sclerosis: moving towards a new classification system
|
journal
|
October 2016 |
|
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
|
journal
|
July 2017 |
|
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
|
journal
|
January 2018 |
|
Implementation of a manual for working with wobbler mice and criteria for discontinuation of the experiment
|
journal
|
July 2015 |
|
Sporadic and hereditary amyotrophic lateral sclerosis (ALS)
|
journal
|
April 2015 |
|
Vulnerability of microRNA biogenesis in FTD–ALS
|
journal
|
September 2016 |
|
Mouse models of ALS: Past, present and future
|
journal
|
August 2018 |
|
Therapeutic Development in Amyotrophic Lateral Sclerosis
|
journal
|
March 2015 |
|
Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: A longitudinal MRI study
|
journal
|
September 2011 |
|
Altered miRNA expression is associated with neuronal fate in G93A-SOD1 ependymal stem progenitor cells
|
journal
|
March 2014 |
|
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
|
journal
|
March 2016 |
|
The ‘Omics’ of Amyotrophic Lateral Sclerosis
|
journal
|
January 2016 |
|
Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis
|
journal
|
January 2013 |
|
Serum microRNAs in sporadic amyotrophic lateral sclerosis
|
journal
|
September 2015 |
|
Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration
|
journal
|
July 2011 |
|
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
|
journal
|
October 2011 |
|
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
|
journal
|
October 2011 |
|
C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
|
journal
|
December 2015 |
|
Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
|
journal
|
December 2015 |
|
C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
|
journal
|
May 2016 |
|
Absence of Survival and Motor Deficits in 500 Repeat C9ORF72 BAC Mice
|
journal
|
November 2020 |
|
Wobbler mice modeling motor neuron disease display elevated transactive response DNA binding protein
|
journal
|
January 2009 |
|
Intralingual and Intrapleural AAV Gene Therapy Prolongs Survival in a SOD1 ALS Mouse Model
|
journal
|
June 2020 |
|
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
|
journal
|
July 2020 |
|
Mir-17∼92 Confers Motor Neuron Subtype Differential Resistance to ALS-Associated Degeneration
|
journal
|
August 2019 |
|
Treatment of a Mouse Model of ALS by In Vivo Base Editing
|
journal
|
April 2020 |
|
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
|
journal
|
January 2012 |
|
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
|
journal
|
March 1993 |
|
MicroRNA-125b regulates microglia activation and motor neuron death in ALS
|
journal
|
January 2016 |
|
FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment
|
journal
|
December 2012 |
|
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis
|
journal
|
May 2015 |
|
C9orf72 nucleotide repeat structures initiate molecular cascades of disease
|
journal
|
March 2014 |
|
Decoding ALS: from genes to mechanism
|
journal
|
November 2016 |
|
MicroRNA miR124 is required for the expression of homeostatic synaptic plasticity
|
journal
|
December 2015 |
|
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|
journal
|
March 2008 |
|
Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse
|
journal
|
October 2005 |
|
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
|
journal
|
August 2004 |
|
MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α–PU.1 pathway
|
journal
|
December 2010 |
|
State of play in amyotrophic lateral sclerosis genetics
|
journal
|
December 2013 |
|
Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF
|
journal
|
February 2006 |
|
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
|
journal
|
February 2008 |
|
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
|
journal
|
November 2011 |
|
The epidemiology of ALS: a conspiracy of genes, environment and time
|
journal
|
October 2013 |
|
The phenotypic variability of amyotrophic lateral sclerosis
|
journal
|
October 2014 |
|
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
|
journal
|
April 2015 |
|
The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a
|
journal
|
June 2007 |
|
Transgenic-Mouse Model of Amyotrophic Lateral Sclerosis
|
journal
|
December 1994 |
|
Amyotrophic Lateral Sclerosis
|
journal
|
July 2017 |
|
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
|
journal
|
January 2002 |
|
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
|
journal
|
July 2007 |
|
miRNA malfunction causes spinal motor neuron disease
|
journal
|
June 2010 |
|
Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis
|
journal
|
October 2011 |
|
TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes
|
journal
|
February 2012 |
|
ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43
|
journal
|
February 2013 |
|
Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS
|
journal
|
December 2013 |
|
Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43
|
journal
|
April 2014 |
|
A20: Central Gatekeeper in Inflammation and Immunity
|
journal
|
March 2009 |
|
SOD1 gene mutations in ALS patients from British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management
|
journal
|
January 2008 |
|
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20
|
journal
|
February 2008 |
|
Therapeutic rAAVrh10 MediatedSOD1Silencing in AdultSOD1G93AMice and Nonhuman Primates
|
journal
|
January 2016 |
|
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor
|
journal
|
December 1998 |
|
Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease
|
journal
|
May 2009 |
|
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice
|
journal
|
June 2013 |
|
l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND
|
journal
|
January 2020 |
|
The Spatiotemporal Pattern of Degeneration in the Cerebellum of the Wobbler Mouse
|
journal
|
March 2016 |
|
New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models
|
journal
|
March 2016 |
|
Nuclear factor TDP‐43 can affect selected microRNA levels
|
journal
|
April 2010 |
|
Screening the expression characteristics of several miRNAs in G93A‐SOD1 transgenic mouse: altered expression of miRNA‐124 is associated with astrocyte differentiation by targeting Sox2 and Sox9
|
journal
|
November 2017 |
|
In vivo genome editing improves motor function and extends survival in a mouse model of ALS
|
journal
|
December 2017 |
|
TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis
|
journal
|
March 2008 |
|
Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6
|
journal
|
February 2009 |
|
Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis
|
journal
|
February 2009 |
|
MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice
|
journal
|
December 2009 |
|
Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques
|
journal
|
October 2018 |
|
MicroRNA-125b Promotes Neuronal Differentiation in Human Cells by Repressing Multiple Targets
|
journal
|
October 2009 |
|
An hereditary motor neurone disease with progressive denervation of muscle in the mouse: the mutant 'wobbler'.
|
journal
|
December 1968 |
|
Motor Neuron Diversity in Development and Disease
|
journal
|
June 2010 |
|
Unraveling the Mechanisms Involved in Motor Neuron Degeneration in als
|
journal
|
July 2004 |
|
ALS and Frontotemporal Dysfunction: A Review
|
journal
|
January 2012 |
|
Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 Polarization
|
journal
|
January 2016 |
|
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
|
journal
|
September 2012 |
|
Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models
|
journal
|
July 2018 |
|
Advances in spinal muscular atrophy therapeutics
|
journal
|
January 2018 |
|
Endosomal accumulation of APP in wobbler motor neurons reflects impaired vesicle trafficking: Implications for human motor neuron disease
|
journal
|
March 2011 |
|
Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels
|
journal
|
May 2013 |
|
Inflammation and neuronal death in the motor cortex of the wobbler mouse, an ALS animal model
|
journal
|
November 2015 |
|
Up-regulation of neural and cell cycle-related microRNAs in brain of amyotrophic lateral sclerosis mice at late disease stage
|
journal
|
January 2015 |
|
Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis
|
journal
|
October 2015 |
|
Analysis of microRNA from archived formalin-fixed paraffin-embedded specimens of amyotrophic lateral sclerosis
|
journal
|
December 2014 |
|
Presymptomatic ALS genetic counseling and testing
|
journal
|
June 2016 |
|
Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival
|
journal
|
July 2008 |
|
MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State
|
journal
|
February 2012 |
|
Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset
|
journal
|
September 2013 |
|
Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis
|
journal
|
January 2014 |
|
The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease
|
journal
|
October 2015 |
|
The Wobbler Mouse: A Neurodegeneration Jigsaw Puzzle
|
journal
|
January 2003 |
|
Behavioral and Neurological Correlates of ALS-Parkinsonism Dementia Complex in Adult Mice Fed Washed Cycad Flour
|
journal
|
January 2002 |
|
Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice
|
journal
|
August 2010 |
|
MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models
|
journal
|
April 2017 |
|
Dysregulated mi RNA biogenesis downstream of cellular stress and ALS ‐causing mutations: a new mechanism for ALS
|
journal
|
September 2015 |
|
The Role of Immune and Inflammatory Mechanisms in ALS
|
journal
|
April 2011 |
|
MicroRNAs: Newcomers into the ALS Picture
|
journal
|
March 2015 |
|
PTEN: A molecular target for neurodegenerative disorders
|
journal
|
January 2012 |
|
The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders
|
journal
|
February 2014 |
|
RNA metabolism in ALS: When normal processes become pathological
|
journal
|
February 2014 |
|
Neuronal dark matter: the emerging role of microRNAs in neurodegeneration
|
journal
|
January 2013 |
|
The role of miRNA in motor neuron disease
|
journal
|
January 2014 |
|
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
|
journal
|
May 2014 |
|
Muscle Expression of SOD1G93A Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice
|
journal
|
December 2015 |
|
Deregulated miR-29b-3p Correlates with Tissue-Specific Activation of Intrinsic Apoptosis in An Animal Model of Amyotrophic Lateral Sclerosis
|
journal
|
September 2019 |
|
Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS
|
journal
|
January 2016 |